Lung Cancer Clinical Trial

A Study of Preferences for the First-Line Treatment of Advanced/Metastatic Non-Small Cell Lung Cancer

Summary

The purpose of this observational study is to determine participants' preferences for outcomes associated with first-line treatment of advanced/metastatic Non-Small Cell Lung Cancer (NSCLC) using a discrete-choice experiment (DCE).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

The following is the inclusion criteria for pretest interviews and final online survey.

Participants:

Must be 18 years of age or older
Must be a US resident.
Lung cancer participants with a physician diagnosis of NSCLC. Global Perspectives will be involved to suggest alternative strategies to a physician-confirmed diagnosis to ensure that actual cancer participants are recruited.

Exclusion Criteria:

Not applicable

Other protocol-defined inclusion/exclusion criteria apply

Study is for people with:

Lung Cancer

Estimated Enrollment:

650

Study ID:

NCT05250817

Recruitment Status:

Recruiting

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

RTI Health Solutions
Research Triangle Park North Carolina, 27709, United States More Info
Eric Ostraat, Site 0001
Contact
919-541-6000
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

650

Study ID:

NCT05250817

Recruitment Status:

Recruiting

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider